# Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

> **NCT03466788** · NA · COMPLETED · sponsor: **Centre Francois Baclesse** · enrollment: 51 (actual)

## Conditions studied

- Endometrial Cancer
- Chemotherapy Effect
- Quality of Life

## Interventions

- **OTHER:** Self questionnaires of quality of life and living conditions

## Key facts

- **NCT ID:** NCT03466788
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2019-03-28
- **Final completion:** 2020-03-28
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466788, "Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03466788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*